MedPath

MYLOTARG

MYLOTARG

Approved
DIN Number

02494388

Drug Class

Human

Market Date

Mar 11, 2020

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02494388
AIG Number0161991001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FX02 GEMTUZUMAB OZOGAMICIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

GEMTUZUMAB OZOGAMICINActive
Strength: 4.5 MG / VIAL
Monograph: GEMTUZUMAB OZOGAMICIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.